Medical management of dysfunctional uterine bleeding

Gillian Anne Irvine; Iain T. Cameron

doi:10.1053/beog.1999.0017

Medical management of dysfunctional uterine bleeding

Gillian Anne Irvine, Iain T. Cameron

In: Best Practice & Research Clinical Obstetrics & Gynaecology · 1999 · vol. 13(2) , pp. 189–202 · doi:10.1053/beog.1999.0017 · PMID:10755037 · W2055748849

review OA: closed CC0 ⤵ 16 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This review examines current medical treatments for dysfunctional uterine bleeding, focusing on hormonal and non-hormonal pharmacologic options.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (62)

A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia via openalex
A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia via openalex
Comparison between mefenamic acid and danazol in the treatment of established menorrhagia via openalex
Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States via openalex
Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid via openalex
Dating the Endometrial Biopsy via openalex
Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia via openalex
Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
Endothelin receptor expression in human decidua via openalex
Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine via openalex
How Do New Zealand Gynaecologists Treat Menorrhagia? via openalex
Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia via openalex
MORPHOLOGY OF HAEMOSTASIS IN MENSTRUAL ENDOMETRIUM via openalex
PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex
Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of Menorrhagia via openalex
REDUCTION OF MENSTRUAL BLOOD LOSS BY DANAZOL IN UNEXPLAINED MENORRHAGIA: LACK OF EFFECT OF PLACEBO via openalex
REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex
THE EFFECT OF DANAZOL ON MENORRHAGIA, COAGULATION MECHANISMS, HAEMATOLOGICAL INDICES AND BODY WEIGHT via openalex
The effects of danazol mefanamic acid, norethistherone and a progesterone-impragnated coil on endometrial prostaglandin concentrations in women with monorrhagia via openalex
Treating Menorrhagia in Primary Care: <i>An Overview of Drug Trials and a Survey of Prescribing Practice</i> via openalex
Use of a super active luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia via openalex
doi:10.1111/j.1471-0528.1985.tb03031.x via openalex
doi:10.1016/s0140-6736(95)91928-7 via openalex
doi:10.1111/j.1471-0528.1995.tb11293.x via openalex
doi:10.1136/bmj.1.5179.1103 via openalex
doi:10.1136/bmj.313.7057.579 via openalex
doi:10.1097/00004347-198609000-00005 via openalex
doi:10.1016/s1074-3804(96)80068-5 via openalex
doi:10.1136/bmj.309.6960.979 via openalex
doi:10.1136/bmj.4.5729.214 via openalex
doi:10.1111/j.1471-0528.1982.tb04727.x via openalex
doi:10.1136/bmj.4.5987.21 via openalex
doi:10.1111/j.1471-0528.1991.tb15369.x via openalex
doi:10.1093/molehr/3.1.69 via openalex
doi:10.1136/bmj.312.7023.83 via openalex
doi:10.1016/s0140-6736(76)90733-9 via openalex
doi:10.1111/j.1471-0528.1983.tb08621.x via openalex
doi:10.1016/0002-9378(71)90259-6 via openalex
W191591924 via openalex
W63062164 via openalex
W2732438387 via openalex
W4285719527 via openalex
doi:10.1055/s-0038-1651301 via openalex
doi:10.1080/00365516409060511 via openalex
doi:10.1016/0002-9378(94)90466-9 via openalex
doi:10.1111/j.1471-0528.1993.tb15237.x via openalex
doi:10.1111/j.1479-828x.1990.tb02028.x via openalex
doi:10.1093/humrep/11.suppl_2.83 via openalex
doi:10.1016/s0140-6736(97)08248-2 via openalex
doi:10.1111/j.1471-0528.1991.tb13484.x via openalex
doi:10.1111/j.1471-0528.1977.tb12490.x via openalex
doi:10.1093/humrep/13.5.1210 via openalex
doi:10.1016/s0140-6736(78)92895-7 via openalex
doi:10.1111/j.1471-0528.1983.tb06751.x via openalex
doi:10.1111/j.1471-0528.1996.tb09666.x via openalex
doi:10.1111/j.1471-0528.1991.tb13460.x via openalex
doi:10.1111/j.1471-0528.1990.tb16249.x via openalex
doi:10.1111/j.1471-0528.1978.tb15826.x via openalex
doi:10.1016/0010-7824(77)90001-4 via openalex
doi:10.1016/0002-9378(78)90119-9 via openalex
doi:10.1111/j.1471-0528.1990.tb01805.x via openalex
doi:10.1111/j.1471-0528.1997.tb11542.x via openalex

Cited by (16)

Source provenance

openalex: last seen: 2026-05-11T05:39:31.692385+00:00
unpaywall: last seen: 2026-06-04T02:00:05.705006+00:00

License: CC0 · commercial use OK

[1] A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia via openalex

[2] A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia via openalex

[3] Comparison between mefenamic acid and danazol in the treatment of established menorrhagia via openalex

[4] Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States via openalex

[5] Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid via openalex

[6] Dating the Endometrial Biopsy via openalex

[7] Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia via openalex

[8] Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex

[9] Endothelin receptor expression in human decidua via openalex

[10] Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine via openalex

[11] How Do New Zealand Gynaecologists Treat Menorrhagia? via openalex

[12] Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia via openalex

[13] MORPHOLOGY OF HAEMOSTASIS IN MENSTRUAL ENDOMETRIUM via openalex

[14] PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex

[15] Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of Menorrhagia via openalex

[16] REDUCTION OF MENSTRUAL BLOOD LOSS BY DANAZOL IN UNEXPLAINED MENORRHAGIA: LACK OF EFFECT OF PLACEBO via openalex

[17] REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex

[18] THE EFFECT OF DANAZOL ON MENORRHAGIA, COAGULATION MECHANISMS, HAEMATOLOGICAL INDICES AND BODY WEIGHT via openalex

[19] The effects of danazol mefanamic acid, norethistherone and a progesterone-impragnated coil on endometrial prostaglandin concentrations in women with monorrhagia via openalex

[20] Treating Menorrhagia in Primary Care: <i>An Overview of Drug Trials and a Survey of Prescribing Practice</i> via openalex

[21] Use of a super active luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia via openalex

[22] doi:10.1111/j.1471-0528.1985.tb03031.x via openalex

[23] doi:10.1016/s0140-6736(95)91928-7 via openalex

[24] doi:10.1111/j.1471-0528.1995.tb11293.x via openalex

[25] doi:10.1136/bmj.1.5179.1103 via openalex

[26] doi:10.1136/bmj.313.7057.579 via openalex

[27] doi:10.1097/00004347-198609000-00005 via openalex

[28] doi:10.1016/s1074-3804(96)80068-5 via openalex

[29] doi:10.1136/bmj.309.6960.979 via openalex

[30] doi:10.1136/bmj.4.5729.214 via openalex

[31] doi:10.1111/j.1471-0528.1982.tb04727.x via openalex

[32] doi:10.1136/bmj.4.5987.21 via openalex

[33] doi:10.1111/j.1471-0528.1991.tb15369.x via openalex

[34] doi:10.1093/molehr/3.1.69 via openalex

[35] doi:10.1136/bmj.312.7023.83 via openalex

[36] doi:10.1016/s0140-6736(76)90733-9 via openalex

[37] doi:10.1111/j.1471-0528.1983.tb08621.x via openalex

[38] doi:10.1016/0002-9378(71)90259-6 via openalex

[39] W191591924 via openalex

[40] W63062164 via openalex

[41] W2732438387 via openalex

[42] W4285719527 via openalex

[43] doi:10.1055/s-0038-1651301 via openalex

[44] doi:10.1080/00365516409060511 via openalex

[45] doi:10.1016/0002-9378(94)90466-9 via openalex

[46] doi:10.1111/j.1471-0528.1993.tb15237.x via openalex

[47] doi:10.1111/j.1479-828x.1990.tb02028.x via openalex

[48] doi:10.1093/humrep/11.suppl_2.83 via openalex

[49] doi:10.1016/s0140-6736(97)08248-2 via openalex

[50] doi:10.1111/j.1471-0528.1991.tb13484.x via openalex

[51] doi:10.1111/j.1471-0528.1977.tb12490.x via openalex

[52] doi:10.1093/humrep/13.5.1210 via openalex

[53] doi:10.1016/s0140-6736(78)92895-7 via openalex

[54] doi:10.1111/j.1471-0528.1983.tb06751.x via openalex

[55] doi:10.1111/j.1471-0528.1996.tb09666.x via openalex

[56] doi:10.1111/j.1471-0528.1991.tb13460.x via openalex

[57] doi:10.1111/j.1471-0528.1990.tb16249.x via openalex

[58] doi:10.1111/j.1471-0528.1978.tb15826.x via openalex

[59] doi:10.1016/0010-7824(77)90001-4 via openalex

[60] doi:10.1016/0002-9378(78)90119-9 via openalex

[61] doi:10.1111/j.1471-0528.1990.tb01805.x via openalex

[62] doi:10.1111/j.1471-0528.1997.tb11542.x via openalex